The new capital will advance the SERRA-I early feasibility study, engineering development, and preparation for additional studies on coronary microvascular dysfunction. SANTA CLARA, Calif.–(BUSINESS WIRE)–VahatiCor, a medtech company transforming cardiac care for Coronary Microvascular Dysfunction (CMD), today announced the successful closing of its $23 million Series B financing led by S3 […]